Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | cytochrome P450 142A3 Cyp142A3 | 0.0053 | 1 | 1 |
Trypanosoma brucei | cytochrome P450, putative | 0.0053 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 monooxygenase 142 Cyp142 | 0.0053 | 1 | 0.5 |
Plasmodium falciparum | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0051 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 130 Cyp130 | 0.0053 | 1 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 126A3 Cyp126A3 | 0.0053 | 1 | 1 |
Leishmania major | lanosterol 14-alpha-demethylase, putative | 0.0053 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | 0.0053 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 141 Cyp141 | 0.0053 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 0 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0051 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 144 Cyp144 | 0.0053 | 1 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 136A2 Cyp136A2 | 0.0053 | 1 | 1 |
Trypanosoma brucei | Lanosterol 14-alpha demethylase | 0.0053 | 1 | 1 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0053 | 1 | 1 |
Onchocerca volvulus | 0.0051 | 0 | 0.5 | |
Mycobacterium tuberculosis | Cytochrome P450 121 Cyp121 | 0.0053 | 1 | 0.5 |
Mycobacterium ulcerans | cytochrome p450 150 cyp150 | 0.0053 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 150A6 Cyp150A6 | 0.0053 | 1 | 1 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0053 | 1 | 0.5 |
Brugia malayi | cytochrome P450 | 0.0053 | 1 | 1 |
Entamoeba histolytica | trans-2,3-enoyl-CoA reductase, putative | 0.0051 | 0 | 0.5 |
Leishmania major | cytochrome p450-like protein | 0.0053 | 1 | 1 |
Mycobacterium leprae | putative cytochrome p450 | 0.0053 | 1 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 143A4 Cyp143A4 | 0.0053 | 1 | 1 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0051 | 0 | 0.5 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0051 | 0 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0053 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0051 | 0 | 0.5 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0053 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 187A5 Cyp187A5 | 0.0053 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 144A4 Cyp144A4 | 0.0053 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0053 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0053 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0053 | 1 | 1 |
Echinococcus granulosus | cytochrome P450 2K1 | 0.0053 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 125 Cyp125 | 0.0053 | 1 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0051 | 0 | 0.5 |
Leishmania major | cytochrome p450-like protein | 0.0053 | 1 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0053 | 1 | 1 |
Plasmodium vivax | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0051 | 0 | 0.5 |
Plasmodium falciparum | polyprenol reductase, putative | 0.0051 | 0 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 125A7 Cyp125A7 | 0.0053 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 140A5 Cyp140A5 | 0.0053 | 1 | 1 |
Mycobacterium tuberculosis | Cytochrome P450 51 Cyp51 (CYPL1) (P450-L1A1) (sterol 14-alpha demethylase) (lanosterol 14-alpha demethylase) (P450-14DM) | 0.0053 | 1 | 0.5 |
Trypanosoma cruzi | cytochrome p450-like protein, putative | 0.0053 | 1 | 1 |
Entamoeba histolytica | steroid 5-alpha reductase, putative | 0.0051 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible cytochrome P450 135B1 Cyp135B1 | 0.0053 | 1 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 188A3 Cyp188A3 | 0.0053 | 1 | 1 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0051 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 140 Cyp140 | 0.0053 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0053 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 51B1 Cyp51B1 | 0.0053 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 189A7 Cyp189A7 | 0.0053 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0053 | 1 | 1 |
Leishmania major | cytochrome p450-like protein | 0.0053 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 187A4 Cyp187A4 | 0.0053 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 105Q4 Cyp105Q4 | 0.0053 | 1 | 1 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0053 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0053 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 124 Cyp124 | 0.0053 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 128 Cyp128 | 0.0053 | 1 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0051 | 0 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0051 | 0 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 | 0.0053 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 143 Cyp143 | 0.0053 | 1 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0053 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 123A3 Cyp123A3 | 0.0053 | 1 | 1 |
Giardia lamblia | Synaptic glycoprotein SC2 | 0.0051 | 0 | 0.5 |
Schistosoma mansoni | cytochrome P450 | 0.0053 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 139 Cyp139 | 0.0053 | 1 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 124A1, Cyp124A1 | 0.0053 | 1 | 1 |
Plasmodium vivax | polyprenol reductase, putative | 0.0051 | 0 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 143A3 Cyp143A3 | 0.0053 | 1 | 1 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0053 | 1 | 1 |
Mycobacterium tuberculosis | Possible cytochrome P450 126 Cyp126 | 0.0053 | 1 | 0.5 |
Mycobacterium tuberculosis | Possible cytochrome P450 135A1 Cyp135A1 | 0.0053 | 1 | 0.5 |
Echinococcus multilocularis | 0.0053 | 1 | 1 | |
Mycobacterium tuberculosis | Probable cytochrome P450 138 Cyp138 | 0.0053 | 1 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 108B4 Cyp108B4 | 0.0053 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 0 | 0.5 |
Entamoeba histolytica | 3-oxo-5-alpha-steroid 4-dehydrogenase domain-containing protein | 0.0051 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 123 Cyp123 | 0.0053 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 132 Cyp132 | 0.0053 | 1 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0053 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 137 Cyp137 | 0.0053 | 1 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 191A3 Cyp191A3 | 0.0053 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
-Log KB (functional) | = 5.19 % | In vitro Histamine H2 receptor antagonist activity in the histamine-stimulated guinea pig right atrium | ChEMBL. | 2894467 |
-Log KB (functional) | = 5.19 % | In vitro Histamine H2 receptor antagonist activity in the histamine-stimulated guinea pig right atrium | ChEMBL. | 2894467 |
Kb (functional) | = 6800 nM | Antagonist activity at guinea pig H2R-Gsalpha fusion protein expressed in sf9 cells by GTPase assay | ChEMBL. | 16730977 |
Kb (functional) | = 15000 nM | Antagonist activity at human H2R-Gsalpha fusion protein expressed in sf9 cells by GTPase assay | ChEMBL. | 16730977 |
Kb (functional) | > 30 uM | Antagonist activity at human recombinant H1R expressed in sf9 cells assessed as inhibition of histamine-stimulated GTP hydrolysis | ChEMBL. | 16730977 |
Kb (functional) | > 30 uM | Antagonist activity at human recombinant H1R expressed in sf9 cells assessed as inhibition of histamine-stimulated GTP hydrolysis | ChEMBL. | 16730977 |
Ratio (functional) | = 2.2 | Ratio of antagonist activity at human H2R-Gsalpha fusion protein to guinea pig H2R-Gsalpha fusion protein expressed in sf9 cells | ChEMBL. | 16730977 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.